Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 3, 2006, Pages 1051-1061

  LoVerme, Jesse ^a   Russo, Roberto ^b   La Rana, Giovanna ^b   Fu, Jin ^a,c   Farthing, Jesse ^a,c   Mattace Raso, Giuseppina ^b   Meli, Rosaria ^b   Hohmann, Andrea ^c   Calignano, Antonio ^b   Piomelli, Daniele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c University of Georgia ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BUTYRIC ACID; CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CELL NUCLEUS RECEPTOR; FENOFIBRIC ACID; FORMALDEHYDE; GW 501516; GW 7647; MAGNESIUM SULFATE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIRINIXIC ACID; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CHEMICAL INJURY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ELECTROPHYSIOLOGY; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NERVE INJURY; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROSCOPY; SPINAL GANGLION; TISSUE INJURY; TISSUE LEVEL;

ANALGESICS; ANIMALS; ANTILIPEMIC AGENTS; DNA, COMPLEMENTARY; DRUG TOLERANCE; FORMALDEHYDE; HYPERALGESIA; IMMUNOBLOTTING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOCICEPTORS; PAIN MEASUREMENT; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PPAR ALPHA; PROCETOFEN; RATS; RATS, SPRAGUE-DAWLEY; RNA; SCIATICA;

EID: 33751166817     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.111385     Document Type: Article

References (39)

1. Ahern GP (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278:30429-30434.
2. Astarita G, Rourke BC, Andersen JB, Fu J, Kim JH, Bennett AF, Hicks JW, and Piomelli D (2006) Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus). Am J Physiol 290:R1407-R1412.
3. Bennett GJ and Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
4. Brown PJ, Stuart LW, Hurley KP, Lewis MC, Winegar DA, Wilson JG, Wilkison WO, Ittoop OR, and Willson TM (2001) Identification of a subtype selective human PPARα agonist through parallel-array synthesis. Bioorg Med Chem Lett 11:1225-1227.
5. Calignano A, La Rana G, Giuffrida A, and Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature (Lond) 394:277-281.
6. Chambliss KL, Simon L, Yuhanna IS, Mineo C, and Shaul PW (2005) Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERα domains with known nuclear functions. Mol Endocrinol 19:277-289.
7. Davies PJ, Thomas EA, and Bornstein JC (2006) Different types of potassium channels underlie the long afterhyperpolarization in guinea-pig sympathetic and enteric neurons. Auton Neurosci 124:26-30.
8. Faber ES and Sah P (2003) Calcium-activated potassium channels: multiple contributions to neuronal function. Neuroscientist 9:181-194.
9. Fagerberg B, Edwards S, Halmos T, Lopatynski J, Schuster H, Stender S, Stoa-Birketvedt G, Tonstad S, Halldorsdottir S, and Gause-Nilsson I (2005) Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population. Diabetologia 48:1716-1725.
10. Fu J, Gaetani S, Oveisi F, LoVerme J, Serrano A, Rodriguez de Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature (Lond) 425:90-93.
11. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
12. Hohmann AG, Tsou K, and Walker JM (1999) Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J Neurophysiol 81:575-583.
13. 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA 100:10529-10533.
14. 2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189-199.
15. Kawasaki Y, Kohno T, Zhuang ZY, Brenner GJ, Wang H, Van Der Meer C, Befort K, Woolf CJ, and Ji RR (2004) Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 24:8310-8321.
16. 2+-activated ion channels in human keratinocytes. FASEB J 15:145-154.
17. Kostadinova R, Wahli W, and Michalik L (2005) PPARs in diseases: control mechanisms of inflammation. Curr Med Chem 12:2995-3009.
18. LoVerme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, and Piomelli D (2005a) The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67:15-19.
19. LoVerme J, La Rana G, Russo R, Calignano A, and Piomelli D (2005b) The search for the palmitoylethanolamide receptor. Life Sci 77:1685-1698.
20. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 93:239-245.
21. Marchand F, Perretti M, and McMahon SB (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6:521-532.
22. Mazzari S, Canella R, Petrelli L, Marcolongo G, and Leon A (1996) N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 300:227-236.
23. Mongan LC, Hill MJ, Chen MX, Tate SN, Collins SD, Buckby L, and Grubb BD (2005) The distribution of small and intermediate conductance calcium-activated potassium channels in the rat sensory nervous system. Neuroscience 131:161-175.
24. Morris CJ (2003) Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol 225:115-121.
25. 2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J Neurophysiol 92:3562-3574.
26. Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, and Malan TP Jr (2003) Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99:955-960.
27. Raffaelli G, Saviane C, Mohajerani MH, Pedarzani P, and Cherubini E (2004) BK potassium channels control transmitter release at CA3-CA3 synapses in the rat hippocampus. J Physiol (Lond) 557:147-157.
28. Randall LO and Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111:409-419.
29. + channel pathway. Proc Natl Acad Sci USA 101:3680-3685.
30. + channels in small neurones of rat dorsal root ganglion studied in a thin slice preparation. J Physiol (Lond) 513:55-69.
31. Singh JP, Kauffman R, Bensch W, Wang G, McClelland P, Bean J, Montrose C, Mantlo N, and Wagle A (2005) Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4- methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3- yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression. Mol Pharmacol 68:763-768.
32. Taylor BK, Dadia N, Yang CB, Krishnan S, and Badr M (2002) Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia. Inflammation 26:121-127.
33. Whiteley PE and Dalrymple SA (2001) Models of inflammation: adjuvant-induced arthritis in the rat, in Current Protocols in Pharmacology (Enna SJ ed) pp 5.5.1-5.5.5, John Wiley & Sons, Inc., New York.
34. Willson TM, Brown PJ, Sternbach DD, and Henke BR (2000) The PPARs: from orphan receptors to drug discovery. J Med Chem 43:527-550.
35. + channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci USA 97:8151-8156.
36. Xu Y, Mayhugh D, Saeed A, Wang X, Thompson RC, Dominianni SJ, Kauffman RF, Singh J, Bean JS, Bensch WR, et al. (2003) Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist. J Med Chem 46:5121-5124.
37. Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, and Arisaka O (2005) Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. Int Arch Allergy Immunol 138:80-87.
38. 2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101:1589-1594.
39. Zhang XF, Gopalakrishnan M, and Shieh CC (2003) Modulation of action potential firing by iberiotoxin and NS1619 in rat dorsal root ganglion neurons. Neuroscience 122:1003-1011.